Table 2.

Outcomes of patients with MRSA pneumonia and patients with non-MRSA pneumonia after 1:4 matching

	MRSA pneumonia		Non-MRSA pneumonia		p-value
In-hospital mortality	967	(31.2)	1429	(11.6)	< 0.001
30-day mortality	382	(12.3)	1011	(8.20)	< 0.001
90-day mortality	809	(26.1)	1330	(10.8)	< 0.001
Length of stay (days)	35.0	[22–62]	14.0	[9–23]	< 0.001
Antibiotic therapy (days)	24.0	[15–45]	9.0	[6–13]	< 0.001
Hospitalisation costs (USD)	12,156	[7827–20,615]	4665	[3163–7298]	< 0.001

Data are expressed as numbers (%) or as medians [interquartile ranges]

MRSA, methicillin-resistant Staphylococcus aureus; USD, United States Dollar